RSV

RSV mRESVIA Label Update and Resources

Moderna has updated several mRESVIA resources to align with recent label changes. Please see details below:

  • Refrigeration Duration: Updated from 30 days to 90 days.

  • Refrigeration Thaw Duration:

    • For 1 carton: Updated from 60 minutes to 100 minutes.

    • For a carton of 10: Updated from 155 minutes to 160 minutes.

  • Room Temperature Thaw Duration:

    • For 1 carton: Updated from 45 minutes to 40 minutes.

    • For a carton of 10: Updated from 160 minutes to 80 minutes.

FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

On July 17, 2023, The U.S. Food and Drug Administration (FDA) approved Beyfortus™, a long-acting antibody for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in all infants born during or entering their first RSV season and in children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season. Here is the full press release with additional information.